Patent · US Expired

Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds

US5315012A · kind A · utility

15Cited by
1References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 9, 1993
Grant dateMay 24, 1994
Priority date
Expiry dateSep 9, 2013

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D231/54
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of the general formula I: ##STR1## are disclosed as useful in the treatment or prevention of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis. Novel intermediate compounds used to make the compound of formula I are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.